first glp-1 approved for weight loss FDA Approves Oral Semaglutide as Pill Weight-loss GLP-1 pill approved for

Dula also significantly reduced the expression of transforming growth factor-1 (TGF-1), phosphatidylinositol-3-kinase (PI3K), protein kinase B (AKT) signaling pathway, and the inflammatory cytokines: nuclear factor kappa B (NF-B), interleukin-6 (IL-6), and interferon- (IFN-) in colonic cellular structures

Discover a study exploring how GLP-1 receptor agonists may reduce symptoms of hidradenitis suppurativa through weight loss and anti-inflammatory effects.

One of our patients, JH, achieved life-changing improvements through a conservative treatment approach using the GLP-1 medication []

This narrative review examines how digital promotion, gray-market access, self-injection, stacking, informal titration, product-quality uncertainty, regulatory ambiguity, and weak pharmacovigilance interact to normalize poorly traceable peptide products outside clinical supervision

A small study offered new data that supports an emerging push to use GLP-1 drugs to manage type 1 diabetes.